2024 ICD-10-CM Diagnosis Code C41

by

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

  • C41 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • Short description: Malignant neoplasm of bone/artic cartl of and unsp sites
  • The 2024 edition of ICD-10-CM C41 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C41 – other international versions of ICD-10 C41 may differ.

Type 1 Excludes

  • malignant neoplasm of bones of limbs (C40.-)
  • malignant neoplasm of cartilage of ear (C49.0)
  • malignant neoplasm of cartilage of eyelid (C49.0)
  • malignant neoplasm of cartilage of larynx (C32.3)
  • malignant neoplasm of cartilage of limbs (C40.-)
  • malignant neoplasm of cartilage of nose (C30.0)

The following code(s) above C41 contain annotation back-references

 that may be applicable to C41:

  • C00-D49  Neoplasms
  • C40-C41  Malignant neoplasms of bone and articular cartilage

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Code annotations containing back-references to C41: